ACE2 in the second act of COVID‐19 syndrome: Peptide dysregulation and possible correction with oestrogen-Reference-Cited by-同舟云学术

ACE2 in the second act of COVID‐19 syndrome: Peptide dysregulation and possible correction with oestrogen

Author:

Zhang Limei¹^ORCID,Zetter Mario A.¹^ORCID,Guerra Enrique C.¹²^ORCID,Hernández Vito S.¹^ORCID,Mahata Sushil K.³^ORCID,Eiden Lee E.⁴^ORCID

Affiliation:

1. Dept. Physiology Laboratory of Systems Neuroscience School of Medicine National Autonomous University of Mexico Mexico City Mexico

2. MD–PhD Program (PECEM) Faculty of Medicine National Autonomous University of Mexico Mexico City Mexico

3. Metabolic Physiology and Ultrastructural Biology Laboratory VA San Diego Healthcare System University California San Diego San Diego CA USA

4. Section on Molecular Neuroscience National Institute of Mental Health, Intramural Research Program National Institutes of Health Bethesda MD USA

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

Reference80 articles.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. COVID-19 and Diarylamidines: The Parasitic Connection;International Journal of Molecular Sciences;2023-04-01